H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: URGN) | Delayed: 38.28 +1.45 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.83 | 52 Week High | $ | |||
| Open | $36.97 | 52 Week Low | $ | |||
| Day High | $38.32 | P/E | N/A | |||
| Day Low | $36.20 | EPS | $ | |||
| Volume | 531,003 | |||||
